Accuray/$ARAY
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Accuray
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.
- Ticker
- $ARAY
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 809
- Headquarters
- Madison, United States
- Website
- www.accuray.com
Accuray Metrics
BasicAdvanced
$9.6M
-
-$5.66
1.38
-
Price and volume
Market cap
$9.6M
Beta
1.38
52-week high
$47.60
52-week low
$2.88
Average daily volume
68K
Financial strength
Current ratio
1.564
Quick ratio
0.544
Long term debt to equity
2.286
Total debt to equity
2.56
Interest coverage (TTM)
-0.07%
Profitability
EBITDA (TTM)
4.257
Gross margin (TTM)
28.01%
Net profit margin (TTM)
-4.41%
Operating margin (TTM)
-0.63%
Effective tax rate (TTM)
-12.94%
Revenue per employee (TTM)
$490,000
Management effectiveness
Return on assets (TTM)
-0.37%
Return on equity (TTM)
-30.23%
Valuation
Price to revenue (TTM)
0.026
Price to book
0.21
Price to tangible book (TTM)
0.36
Growth
Revenue change (TTM)
-12.50%
Earnings per share change (TTM)
-21.28%
3-year revenue growth (CAGR)
-4.64%
10-year revenue growth (CAGR)
-0.03%
3-year earnings per share growth (CAGR)
25.79%
10-year earnings per share growth (CAGR)
-6.59%
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.